MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing offers insights into Multiple System Atrophy, aiding in early diagnosis, personalized treatments, and advancing research for better outcomes.
Explore how genetic testing aids in early diagnosis, personalized treatment, and monitoring of chronic myeloproliferative disorder with eosinophilia.
Explore how genetic testing aids in diagnosing Myhre Syndrome, improves personalized treatment, and supports family planning. Uncover future directions in genetic research.
Explore how genetic testing advances the diagnosis and personalized treatment of Newfoundland Cone-Rod Dystrophy for better vision management outcomes.
Explore the impact of genetic testing on nonpapillary RCC, revealing insights into mutations, personalized treatments, and improved patient outcomes in kidney cancer care.
Unlock the potential of genetic testing for North Carolina Macular Dystrophy. Explore early diagnosis, personalized treatments, and groundbreaking research advancements.
Explore how genetic testing offers diagnostic clarity and personalized treatment for oculootoradial syndrome, enhancing patient care and genetic counseling.
Explore how genetic testing for Osteoarthritis Susceptibility 2 enables personalized management, identifying risks, tailoring treatment, and guiding lifestyle changes.